New ANDA Cases

Fall 2015

GENERICally Speaking
Case Name Date Filed Judge Drug Patent No(s).
Gilead Sciences, Inc. v. Lupin Pharms., Inc., 15-1956 (D. Md.) July 1, 2015 Hon. J. Frederick Motz Tamiflu® (oseltamivir phosphate capsules) 5,763,483
Otsuka Pharm. Co., Ltd. v. MaCleods Pharms. Ltd., 15-5109 (D.N.J.) July 2, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,017,615 
8,580,796
8,642,760 
8,759,350
Dr. Reddy’s Labs., Ltd. v. Helsinn Healthcare S.A., IPR2015-01550 (PTAB) July 3, 2015 N/A Aloxi® (palonosetron hydrochloride for injection) 8,729,094
Dr. Reddy’s Labs., Ltd. v. Helsinn Healthcare S.A., IPR2015-01551 (PTAB) July 3, 2015 N/A Aloxi® (palonosetron hydrochloride for injection) 8,729,094
Dr. Reddy’s Labs., Ltd. v. Helsinn Healthcare S.A., IPR2015-01553 (PTAB) July 3, 2015 N/A Aloxi® (palonosetron hydrochloride for injection) 8,729,094
Dr. Reddy’s Labs., Ltd. v. Helsinn Healthcare S.A., IPR2015-01554 (PTAB) July 3, 2015 N/A Aloxi® (palonosetron hydrochloride for injection) 8,729,094
Eli Lilly and Co. v. Lupin Pharms., Inc., 15-1047 (S.D. Ind.) July 6, 2015 Hon. Sarah Evans Barker Axiron® (testosterone metered transdermal solution)
8,419,307 
8,177,449 
8,435,944 
8,807,861 
8,993,520
Prinston Pharm., Inc. v. Noven Therapeutics, LLC, 15-5308 (D.N.J.) July 7, 2015 Hon. Claire C. Cecchi Brisdelle® (paroxetine mesylate capsules) 8,946,251
Eli Lilly and Co. v. Lupin Pharms., Inc., 15-0877 (E.D. Va.) July 6, 2015 Hon. Anthony J. Trenga Axiron® (testosterone metered transdermal solution)
8,419,307
8,177,449 
8,435,944 
8,807,861 
8,993,520
Celgene Corp. v. Teva Pharms. USA, Inc., 15-0589 (D. Del.) July 10, 2015 Hon. Richard G. Andrews Istodax® (romidepsin for injection)
7,608,280 
7,611,724
R-Tech Ueno, Ltd. v. Apotex, Inc., 15-0592 (D. Del.) July 10, 2015 Hon. Sue L. Robinson Rescula® (unoprostone isopropyl ophthalmic solution)
6,770,675 
6,458,836
Eli Lilly and Co. v. Mylan Labs. Ltd., 15-1083 (S.D. Ind.) July 10, 2015 Hon. Sarah Evans Barker Alimta® (pemetrexed for injection) 7,772,209
Fresenius Kabi USA, LLC v. Cubist Pharms., Inc., IPR2015-01566 (PTAB) July 10, 2015 N/A Cubicin® (daptomycin for injection) 8,129,342
Fresenius Kabi USA, LLC v. Cubist Pharms., Inc., IPR2015-01570 (PTAB) July 10, 2015 N/A Cubicin® (daptomycin for injection) 8,058,238
Fresenius Kabi USA, LLC v. Cubist Pharms., Inc., IPR2015-01571 (PTAB) July 10, 2015 N/A Cubicin® (daptomycin for injection) 8,058,238
Fresenius Kabi USA, LLC v. Cubist Pharms., Inc., IPR2015-01572 (PTAB) July 10, 2015 N/A Cubicin® (daptomycin for injection) 8,058,238
Senju Pharm. Co., Ltd. v. Watson Labs., Inc., 15-5591 (D.N.J.) July 16, 2015 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution)
8,129,431 
8,669,290 
8,754,131 
8,871,813 
8,927,606
Gilead Sciences, Inc. v. Sigmapharm Labs., LLC, 15-3950 (E.D. Pa.) July 16, 2015 Hon. Gerald J. Pappert Letairis® (ambrisentan tablets) RE42,462
Meda Pharms Inc. v. Amneal Pharms. LLC, 15-0617 (D. Del.) July 17, 2015 Hon. Gregory M. Sleet Astepro® (azelastine hydrochloride nasal spray)
8,071,073 
8,518,919
Roxane Labs., Inc. v. Novel Labs., Inc., 15-5618 (D.N.J.) July 17, 2015 Hon. Stanley R. Chesler Phoslo® (calcium acetate tablet) 8,563,032
Jazz Pharms., Inc. v. Wockhardt Bio AG, 15-5619 (D.N.J.) July 17, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution)
6,472,431 
6,780,889 
7,262,219 
7,851,506 
8,263,650 
8,324,275 
8,461,203 
7,668,730 
7,765,106 
7,765,107 
7,895,059 
8,457,988 
8,589,182 
8,731,963 
8,772,306 
8,859,619 
8,952,062
Spectrum Pharms., Inc. v. Actavis LLC, 15-1360 (D. Nev.) July 17, 2015 Hon. James C. Mahan Fusilev® (levoleucovorin calcium for injection) 6,500,829
Alcon Research, Ltd. v. Lupin Ltd., 15-0621 (D. Del.) July 20, 2015 Hon. Sue L. Robinson Travatan Z® (travoprost ophthalmic solution)
8,268,299
8,323,630 
8,388,941
United Therapeutics Corp. v. Watson Labs., Inc., 15-5723 (D.N.J.) July 22, 2015 Hon. Peter G. Sheridan Tyvaso® (treprostinil inhalation solution)
6,521,212 
6,756,033 
8,497,393
Alcon Pharms. Ltd. v. Dr. Reddy’s Labs., Inc., 15-5756 (D.N.J.) July 24, 2015 Hon. Peter G. Sheridan Ciprodex® (ciprofloxacin / dexamethasone otic suspension)
6,284,804
6,359,016
Lannett Holdings, Inc. v. AstraZeneca AB, IPR2015-01629 (PTAB) July 28, 2015 N/A Zomig® (zolmitriptan nasal spray) 6,750,237
Lannett Holdings, Inc. v. AstraZeneca AB, IPR2015-01630 (PTAB) July 28, 2015 N/A Zomig® (zolmitriptan nasal spray) 7,220,767
Mylan Pharma Acquisition LTD v. Fresenius Kabi USA, LLC, 15-6700 (N.D. Ill.) July 30, 2015 Hon. Rebecca R. Pallmeyer Ultiva® (remifentanil hydrochloride for Injection) 5,866,591
Janssen Pharmaceutica N.V. v. Fera Pharms., LLC, 15-5997 (S.D.N.Y.) July 30, 2015 Hon. P. Kevin Castel Sporanox® (itraconazole oral solution) 6,407,079
Cosmo Technologies Ltd. v. Lupin Ltd., 15-0669 (D. Del.) July 31, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets)
7,410,651
RE43,799
Galderma Labs., L.P. v. Dr. Reddy’s Labs., Ltd., 15-0670 (D. Del.) July 31, 2015 Hon. Leonard P. Stark Oracea® (doxycycline capsules)
7,211,267 
7,232,572 
8,603,506 
7,749,532 
8,206,740 
8,394,405 
8,394,406 
8,470,364
8,709,478
BTG Int’l Ltd. v. Actavis Labs. FL, Inc., 15-5909 (D.N.J.) July 31, 2015 Hon. Kevin McNulty Zytiga® (abiraterone acetate tablets)
5,604,213
8,822,438
Validus Pharms. LLC v. Aurobindo Pharma Ltd., 15-5912 (D.N.J.) July 31, 2015 Hon. Michael A. Shipp Equetro® (carbamazepine extended-release capsules) 6,977,253
Sawai USA, Inc. v. Nissan Chemical Industries Ltd., IPR2015-01647 (PTAB) July 31, 2015 N/A Livalo® (pitavastatin calcium tablets) 5,856,336
Sawai USA, Inc. v. Nissan Chemical Industries Ltd., IPR2015-01648 (PTAB) July 31, 2015 N/A Livalo® (pitavastatin calcium tablets) 5,856,336
Janssen Biotech, Inc. v. Amneal Pharms. LLC, 15-0679 (D. Del.) Aug. 3, 2015 Hon. Sue L. Robinson Zytiga® (abiraterone acetate tablets) 8,822,438
BTG International Ltd. v. Actavis Labs. FL, Inc., 15-81076 (S.D. Fla.) Aug. 3, 2015 Hon. Donald M. Middlebrooks Zytiga® (abiraterone acetate tablets)
5,604,213
8,822,438
Boehringer Ingelheim Pharms. Inc. v. HEC Pharm Group, 15-5982 (D.N.J.) Aug. 4, 2015 Hon. Peter G. Sheridan
Tradjenta® (linagliptin tablets) 
 
Jentadueto® (linagliptin / metformin hydrochloride tablets)
7,407,955 
8,119,648 
8,178,541 
8,673,927 
8,846,695 
8,853,156
Janssen Biotech, Inc. v. Mylan Pharms. Inc., 15-0130 (N.D.W.V.) Aug. 4, 2015 Hon. Irene M. Keeley Zytiga® (abiraterone acetate tablets) 8,822,438
Purdue Pharma L.P. v. Actavis Labs. FL, Inc., 15-0686 (D. Del.) Aug. 5, 2015 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets)
6,733,783
8,361,499 
8,551,520 
8,647,667 
9,023,401 
8,529,948 
8,808,740 
8,309,060
Purdue Pharma L.P. v. Alvogen Pine Brook, Inc., 15-0687 (D. Del.) Aug. 5, 2015 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets)
6,733,783 
8,361,499 
8,551,520 
8,647,667 
9,023,401 
8,529,948 
8,808,740 
8,309,060
AstraZeneca AB v. HEC Pharm Co., Ltd., 15-6025 (D.N.J.) Aug. 5, 2015 Hon. Mary L. Cooper Nexium® (esomeprazole magnesium delayed-release tablets)
6,369,085 
7,411,070 
8,466,175
Purdue Pharma L.P. v. Collegium Pharm., Inc., 15-13099 (D. Mass.) Aug. 6, 2015 Hon. F. Dennis Saylor, IV
OxyContin® (oxycodone extended-release tablets)
 
Xtampza ER™ (oxycodone extended-release capsules)
7,674,799 
7,674,800 
7,683,072 
8,652,497
Purdue Pharm. Products L.P. v. Lannett Holdings, Inc., 15-6036 (D.N.J.) Aug. 6, 2015 Hon. Susan D. Wigenton Dilaudid® (hydromorphone hydrochloride oral solution) 6,589,960
AstraZeneca Pharms. LP v. Agila Specialties, Inc., 15-6039 (D.N.J.) Aug. 6, 2015 Hon. Renee Marie Bumb Faslodex® (fulvestrant injection)
6,774,122 
7,456,160 
8,329,680 
8,466,139
Merck Sharp & Dohme Corp. v. Actavis Labs. FL, Inc., 15-6075 (D.N.J.) Aug. 6, 2015 Hon. Peter G. Sheridan Noxafil® (posaconazole delayed-release tablets) 5,661,151
Collegium Pharm., Inc. v. Purdue Pharma L.P., 15-6179 (S.D.N.Y.) Aug. 6, 2015 Hon. Katherine B. Forrest
OxyContin® (oxycodone extended-release tablets) 
 
Xtampza ER™ (oxycodone extended-release capsules)
7,674,799 
7,674,800 
7,683,072 
8,652,497
Eli Lilly and Co. v. Emcure Pharms Ltd., 15-1244 (S.D. Ind.) Aug. 7, 2015 Hon. Jane Magnus-Stinson Alimta® (pemetrexed for injection) 7,772,209
AstraZeneca AB v. Lupin Ltd., 15-6092 (D.N.J.) Aug. 7, 2015 Hon. Mary L. Cooper Nexium 24HR® (esomeprazole magnesium delayed-release capsules)
6,369,085 
7,411,070
Coalition for Affordable Drugs VII LLC v. Pozen Inc., IPR2015-01680 (PTAB) Aug. 7, 2015 N/A Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) 8,852,636
Hospira, Inc. v. Amneal Pharms. LLC, 15-0697 (D. Del.) Aug. 11, 2015 Hon. Richard G. Andrews Precedex® (dexmedetomidine hydrochloride injection)
8,242,158 
8,338,470 
8,455,527 
8,648,106
Par Pharm., Inc. v. TWi Pharms., Inc., 15-0698 (D. Del.) Aug. 11, 2015 Hon. Sue L. Robinson Megace® ES (megestrol acetate oral suspension)
9,101,540 
9,101,549
Boehringer Ingelheim Pharms. Inc. v. Intas Pharms., Ltd., 15-0664 (M.D.N.C.) Aug. 11, 2015 Hon. Catherine C. Eagles Jentadueto® (linagliptin / metformin hydrochloride tablets)
8,673,927 
8,846,695
Horizon Pharma Ireland Ltd v. Actavis Labs. UT, Inc., 15-6131 (D.N.J.) Aug. 11, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,101,591
Horizon Pharma Ireland Ltd v. Amneal Pharms. LLC, 15-6132 (D.N.J.) Aug. 11, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,101,591
Horizon Pharma Ireland Ltd v. IGI Labs., Inc., 15-6134 (D.N.J.) Aug. 11, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,101,591
Horizon Pharma Ireland Ltd v. Taro Pharms. USA, Inc., 15-6135 (D.N.J.) Aug. 11, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,101,591
Coalition for Affordable Drugs VII LLC v. Horizon Pharma USA, Inc., IPR2015-01718 (PTAB) Aug. 12, 2015 N/A Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) 8,945,621
Millennium Pharms., Inc. v. Pharmascience Inc., 15-0702 (D. Del.) Aug. 13, 2015 Hon. Gregory M. Sleet Velcade® (bortezomib for injection)
6,713,446 
6,958,319
Coalition for Affordable Drugs IX LLC v. Bristol-Myers Squibb Co., IPR2015-01723 (PTAB) Aug. 13, 2015 N/A Eliquis® (apixaban tablets) 6,967,208
Noven Therapeutics, LLC v. Actavis Labs. FL, Inc., 15-6225 (D.N.J.) Aug. 14, 2015 Hon. Claire C. Cecchi Brisdelle® (paroxetine mesylate capsules) 8,946,251
Vivus, Inc. v. Actavis Labs. FL, Inc., 15-6256 (D.N.J.) Aug. 17, 2015 Hon. Stanley R. Chesler Qsymia® (phentermine / topiramate extended-release capsules)
9,011,905 
9,011,906
Par Pharm., Inc. v. TWi Pharms., Inc., 15-0710 (D. Del.) Aug. 18, 2015 Hon. Sue L. Robinson Megace® ES (megestrol acetate oral suspension) 9,107,827
Dr. Reddy’s Labs., Inc. v. Fresenius Kabi USA, LLC, 15-0714 (D. Del.) Aug. 18, 2015 Hon. Richard G. Andrews Diprivan® (propofol injectable emulsion) 8,476,010
Lupin Ltd. v. Pozen, Inc., IPR2015-01773 (PTAB) Aug. 19, 2015 N/A Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) 8,858,996
Lupin Ltd. v. Pozen, Inc., IPR2015-01774 (PTAB) Aug. 19, 2015 N/A Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) 8,852,636
Lupin Ltd. v. Pozen, Inc., IPR2015-01775 (PTAB) Aug. 19, 2015 N/A Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) 8,865,190
Coalition for Affordable Drugs X LLC v. Anacor Pharms., Inc., IPR2015-01776 (PTAB) Aug. 20, 2015 N/A Kerydin® (Tavaborole topical solution) 7,582,621
Dr. Reddy’s Labs., Ltd. v. Galderma Labs., Inc., IPR2015-01777 (PTAB) Aug. 20, 2015 N/A Oracea® (doxycycline capsules) 8,603,506
Dr. Reddy’s Labs., Ltd. v. Galderma Labs., Inc., IPR2015-01778 (PTAB) Aug. 20, 2015 N/A Oracea® (doxycycline capsules) 8,603,506
Coalition for Affordable Drugs X LLC v. Anacor Pharms., Inc., IPR2015-01780 (PTAB) Aug. 20, 2015 N/A Kerydin® (Tavaborole topical solution) 7,767,657
Dr. Reddy’s Labs., Ltd. v. Galderma Labs., Inc., IPR2015-01782 (PTAB) Aug. 20, 2015 N/A Oracea® (doxycycline capsules) 8,603,506
Coalition for Affordable Drugs X LLC v. Anacor Pharms., Inc., IPR2015-01785 (PTAB) Aug. 20, 2015 N/A Kerydin® (Tavaborole topical solution) 7,767,657
Merck Sharp & Dohme Corp. v. Savior Lifetec Corp., 15-0415 (E.D.N.C.) Aug. 21, 2015 Hon. Terrence W. Boyle Invanz® (ertapenem for injection) 5,952,323
Otsuka Pharm. Co., Ltd. v. Standard Chem. & Pharm. Co., Ltd., 15-6353 (D.N.J.) Aug. 21, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,017,615 
8,580,796 
8,642,760 
8,759,350
Sumitomo Dainippon Pharma Co., Ltd. v. Teva Pharms. USA, Inc., 15-6401 (D.N.J.) Aug. 24, 2015 Hon. Stanley R. Chesler Latuda® (lurasidone hydrochloride tablets) 5,532,372
Allergan Inc, v. Teva Pharms. USA, Inc., 15-1455 (E.D. Tex.) Aug. 24, 2015 Hon. Rodney Gilstrap Restasis® (cyclosporine ophthalmic emulsion)
8,629,111 
8,633,162 
8,642,556 
8,648,048 
8,685,930
Coalition for Affordable Drugs XI LLC v. Insys Pharma, Inc., IPR2015-01797 (PTAB) Aug. 24, 2015 N/A Subsys® (fentanyl sublingual spray) 8,835,459
Coalition for Affordable Drugs XI LLC v. Insys Pharma, Inc., IPR2015-01799 (PTAB) Aug. 24, 2015 N/A Subsys® (fentanyl sublingual spray) 8,835,460
Coalition for Affordable Drugs XI LLC v. Insys Pharma, Inc., IPR2015-01800 (PTAB) Aug. 24, 2015 N/A Subsys® (fentanyl sublingual spray) 8,486,972
Cephalon, Inc. v. Panacea Biotec, Ltd., 15-0735 (D. Del.) Aug. 25, 2015 Hon. Sue L. Robinson Treanda® (bendamustine hydrochloride for infusion)
8,445,524 
8,791,270 
8,669,279 
8,883,836 
8,895,756
Boehringer Ingelheim Pharms. Inc. v. Mylan Pharms., Inc., 15-0145 (N.D.W.V.) Aug. 25, 2015 Hon. John Preston Bailey
Tradjenta® (linagliptin tablets) 
 
Jentadueto® (linagliptin / metformin hydrochloride tablets)
8,673,927 
8,846,695 
8,853,156
The Medicines Co. v. Sagent Pharms., Inc., 15-7507 (N.D. Ill.) Aug. 26, 2015 Hon. Harry D. Leinenweber Angiomax® (bivalirudin for injection)
7,582,727 
7,598,343
Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-01810 (PTAB) Aug. 26, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,895,059
Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-01817 (PTAB) Aug. 26, 2015 N/A Xyrem® (sodium oxybate oral solution) 8,457,988
Forest Labs., LLC v. Amneal Pharms. LLC, 15-0756 (D. Del.) Aug. 27, 2015 Hon. Leonard P. Stark Namzaric® (memantine hydrochloride / donepezil hydrochloride extended-release capsules)
8,039,009 
8,058,291 
8,168,209 
8,173,708 
8,283,379 
8,293,794 
8,329,752 
8,338,485 
8,338,486 
8,362,085 
8,580,858 
8,598,233
Wockhardt Bio AG v. Jazz Pharms., Inc., IPR2015-01813 (PTAB) Aug. 27, 2015 N/A Xyrem® (sodium oxybate oral solution) 8,589,182
Wockhardt Bio AG v. Jazz Pharms., Inc., IPR2015-01814 (PTAB) Aug. 27, 2015 N/A Xyrem® (sodium oxybate oral solution) 8,457,988
Wockhardt Bio AG v. Jazz Pharms., Inc., IPR2015-01815 (PTAB) Aug. 27, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,765,106
Wockhardt Bio AG v. Jazz Pharms., Inc., IPR2015-01816 (PTAB) Aug. 27, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,895,059
Wockhardt Bio AG v. Jazz Pharms., Inc., IPR2015-01818 (PTAB) Aug. 27, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,668,730
Wockhardt Bio AG v. Jazz Pharms., Inc., IPR2015-01820 (PTAB) Aug. 27, 2015 N/A Xyrem® (sodium oxybate oral solution) 7,765,107
Warner Chilcott (US), LLC v. Teva Pharms. USA, Inc., 15-1471 (E.D. Tex.) Aug. 28, 2015 Hon. Rodney Gilstrap Delzicol® (mesalamine delayed-release capsules) 6,649,180
Galderma Labs., L.P. v. Taro Pharms. U.S.A., Inc., 15-2814 (N.D. Tex.) Aug. 28, 2015 Hon. Ed Kinkeade Epiduo® (adapalene /benzoyl peroxide gel)
8,071,644 
8,080,537 
8,129,362  
8,445,543 
8,809,305
Coalition for Affordable Drugs VIII LLC v. The Trustees of The University of Pennsylvania, IPR2015-01835 (PTAB) Aug. 28, 2015 N/A Juxtapid® (lomitapide mesylate capsules) 8,618,135
Coalition for Affordable Drugs VIII LLC v. The Trustees of The University of Pennsylvania, IPR2015-01836 (PTAB) Aug. 28, 2015 N/A Juxtapid® (lomitapide mesylate capsules) 7,932,268
Janssen Pharmaceutica, N.V. v. Mylan Pharms., Inc., 15-0760 (D. Del.) Aug. 31, 2015 Hon. Sue L. Robinson Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets)
8,841,310 
7,125,879 
8,101,629
Warner Chilcott (US), LLC v. Teva Pharms. USA, Inc., 15-0761 (D. Del.) Aug. 31, 2015 Hon. Gregory M. Sleet Delzicol® (mesalamine delayed-release capsules) 6,649,180
Merck Sharp & Dohme Corp. v. Actavis Labs. FL, Inc., 15-6541 (D.N.J.) Aug. 31, 2015 Hon. William H. Walls Dificid® (fidaxomicin tablets)
7,906,489 
8,586,551 
7,378,508 
7,863,249 
8,859,510
Gilead Sciences, Inc. v. Mylan Inc., 15-0149 (N.D.W.V.) Aug. 31, 2015 Hon. Irene M. Keeley Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets)
6,642,245 
6,703,396 
8,592,397 
8,716,264
Jazz Pharms., Inc. v. Lupin Ltd., 15-6548 (D.N.J.) Sept. 1, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution)
6,472,431 
6,780,889 
7,262,219 
7,851,506 
8,263,650 
8,324,275 
8,461,203 
7,668,730 
7,765,106 
7,765,107 
7,895,059 
8,457,988
8,589,182 
8,731,963 
8,772,306 
8,859,619 
8,952,062 
9,050,302
Osi Pharms., LLC v. Apotex Inc., 15-0772 (D. Del.) Sept. 2, 2015 Hon. Sue L. Robinson Tarceva® (erlotinib hydrochloride tablets) 6,900,221
Merck Sharp & Dohme Corp. v. Actavis Labs. FL, Inc., 15-61858 (S.D. Fla.) Sept. 2, 2015 Hon. Kathleen M. Williams Dificid® (fidaxomicin tablets)
7,906,489 
8,586,551 
7,378,508 
7,863,249 
8,859,510
Omeros Corp. v. Par Sterile Products, LLC, 15-6561 (D.N.J.) Sept. 2, 2015 Hon. Jose L. Linares Omidria® (phenylephrine / ketorolac injection)
8,173,707 
8,586,633 
9,066,856
Jazz Pharms., Inc. v. Amneal Pharms. LLC, 15-6562 (D.N.J.) Sept. 2, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 9,050,302
AstraZeneca AB v. Alkem Labs. Ltd., 15-6609 (D.N.J.) Sept. 2, 2015 Hon. Mary L. Cooper Nexium® (esomeprazole magnesium delayed-release capsules)
6,369,085 
7,411,070 
8,466, 175
AstraZeneca AB v. Actavis Elizabeth LLC, 15-6610 (D.N.J.) Sept. 2, 2015 Hon. Mary L. Cooper Nexium 24HR® (esomeprazole magnesium delayed-release capsules)
6,369,085 
7,411,070
Janssen Pharmaceutica, N.V. v. Mylan Pharms., Inc., 15-0152 (N.D.W.V.) Sept. 2, 2015 Hon. Irene M. Keeley Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets)
8,841,310 
7,125,879 
8,101,629
Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc., IPR2015-01850 (PTAB) Sept. 2, 2015 N/A Ampyra® (dalfampridine extended-release tablets) 8,440,703
Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc., IPR2015-01853 (PTAB) Sept. 2, 2015 N/A Ampyra® (dalfampridine extended-release tablets) 8,007,826
Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc., IPR2015-01857 (PTAB) Sept. 2, 2015 N/A Ampyra® (dalfampridine extended-release tablets) 8,663,685
Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc., IPR2015-01858 (PTAB) Sept. 2, 2015 N/A Ampyra® (dalfampridine extended-release tablets) 8,354,437
Omeros Corp. v. Par Sterile Products, LLC, 15-0773 (D. Del.) Sept. 3, 2015 Hon. Richard G. Andrews Omidria® (phenylephrine / ketorolac injection)
8,173,707 
8,586,633 
9,066,856
Spectrum Pharms., Inc. v. Amneal Pharms. LLC, 15-1697 (D. Nev.) Sept. 3, 2015 Hon. James C. Mahan Fusilev® (levoleucovorin calcium for injection) 6,500,829
Purdue Pharma L.P. v. Alvogen Pine Brook, Inc., 15-0784 (D. Del.) Sept. 4, 2015 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets)
9,056,052 
9,060,940
Lupin Ltd. v. Senju Pharm. Co., Ltd., IPR2015-01871 (PTAB) Sept. 4, 2015 N/A Prolensa® (bromfenac ophthalmic solution) 8,129,431
Allergan, Inc. v. Innopharma, Inc., 15-1504 (E.D. Tex.) Sept. 8, 2015 Hon. Rodney Gilstrap Restasis® (cyclosporine ophthalmic emulsion)
8,629,111 
8,633,162 
8,642,556 
8,648,048 
8,685,930
Meda Pharms. Inc. v. Teva Pharms. USA, Inc., 15-0785 (D. Del.) Sept. 8, 2015 Hon. Leonard P. Stark Dymista® (azelastine hydrochloride / fluticasone propionate nasal spray)
8,163,723 
8,168,620
Millennium Pharms., Inc. v. Hospira, Inc., 15-0804 (D. Del.) Sept. 10, 2015 Hon. Richard G. Andrews Velcade® (bortezomib for injection)
6,713,446 
6,958,319
Janssen Pharmaceutica N.V. v. Apotex Inc., 15-7121 (S.D.N.Y.) Sept. 10, 2015 Hon. William H. Pauley, III Sporanox® (itraconazole oral solution) 6,407,079
Kowa Co., Ltd. v. Zydus Pharms. (USA) Inc., 15-7136 (S.D.N.Y.) Sept. 10, 2015 Hon. Paul A. Crotty Livalo® (pitavastatin calcium tablets) 6,465,477
Merck Sharp & Dohme B.V. v. Teva Pharms. USA, Inc., 15-0806 (D. Del.) Sept. 11, 2015 Hon. Gregory M. Sleet NuvaRing® (ethinyl estradiol / etonogestrel vaginal ring) 5,989,581
Kowa Co., Ltd. v. Zydus Pharms. (USA) Inc., 15-6792 (D.N.J.) Sept. 11, 2015 Hon. Freda L. Wolfson Livalo® (pitavastatin calcium tablets) 6,465,477
Depomed, Inc. v. Actavis Elizabeth LLC, 15-6797 (D.N.J.) Sept. 11, 2015 Hon. Claire C. Cecchi Nucynta® ER (tapentadol hydrochloride extended-release tablets) 8,536,130
Allergan Inc, v. Teva Pharms. USA, Inc., 15-0815 (D. Del.) Sept. 14, 2015 Hon. Sue L. Robinson Restasis® (cyclosporine ophthalmic emulsion)
8,629,111 
8,633,162 
8,642,556 
8,648,048 
8,685,930
Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2015-01903 (PTAB) Sept. 14, 2015 N/A Xyrem® (sodium oxybate oral solution) 8,731,963
Otsuka Pharm. Co., Ltd. v. Hetero USA Inc., 15-0822 (D. Del.) Sept. 15, 2015 Hon. Richard G. Andrews Samsca® (tolvaptan tablets) 5,753,677
Acorda Therapeutics, Inc. v. Par Pharm., Inc., 15-0824 (D. Del.) Sept. 15, 2015 Hon. Leonard P. Stark Ampyra® (dalfampridine extended-release tablets)
8,007,826 
8,354,437 
8,440,703 
8,663,685
Gilead Sciences, Inc. v. Lupin Pharms., Inc., 15-2793 (D. Md.) Sept. 16, 2015 Hon. J. Frederick Motz Tamiflu® (oseltamivir phosphate capsules) 5,763,483
Purdue Pharma L.P. v. Amneal Pharms. LLC, 15-0831 (D. Del.) Sept. 17, 2015 Hon. Sue L. Robinson OxyContin® (oxycodone extended-release tablets)
9,060,976 
9,034,376
Impax Labs., Inc. v. Actavis Labs. FL, Inc., 15-6934 (D.N.J.) Sept. 17, 2015 Hon. Katharine S. Hayden Rytary® (levodopa / carbidopa capsules)
7,094,427 
8,377,474 
8,454,998 
8,557,283 
9,089,607 
9,089,608
Horizon Pharma Ireland Ltd. v. Lupin Ltd., 15-6935 (D.N.J.) Sept. 17, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,132,110
Horizon Pharma Ireland Ltd. v. Actavis Labs. UT, Inc., 15-6989 (D.N.J.) Sept. 17, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,132,110
Horizon Pharma Ireland Ltd. v. Amneal Pharms. LLC, 15-6990 (D.N.J.) Sept. 17, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,132,110
Horizon Pharma Ireland Ltd. v. IGI Labs., Inc., 15-6991 (D.N.J.) Sept. 17, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,132,110
Bayer Pharma AG v. alembic Pharms. Ltd., 15-0832 (D. Del.) Sept. 18, 2015 Hon. Gregory M. Sleet Staxyn® (vardenafil hydrochloride tablets) 8,613,950
Vivus, Inc. v. Teva Pharms. USA, Inc., 15-6957 (D.N.J.) Sept. 18, 2015 Hon. Stanley R. Chesler Qsymia® (phentermine / topiramate extended-release capsules)
9,011,905 
9,011,906
AstraZeneca Pharms. LP v. Mylan Pharms. Inc., 15-7009 (D.N.J.) Sept. 21, 2015 Hon. Renee Marie Bumb Faslodex® (fulvestrant injection)
6,774,122 
7,456,160 
8,329,680 
8,466,139
Astellas Pharma Inc. v. Apotex Inc., 15-0857 (D. Del.) Sept. 22, 2015 Hon. Sue L. Robinson Mycamine® (micafungin sodium for injection)
6,107,458 
6,774,104
Taro Pharms. U.S.A., Inc. v. Perrigo UK Finco Ltd., 15-0859 (D. Del.) Sept. 22, 2015 Hon. Richard G. Andrews Topicort® (desoximetasone topical spray)
8,277,780 
8,715,624
Helsinn Healthcare S.A. v. Fresenius Kabi USA, LLC, 15-7015 (D.N.J.) Sept. 23, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride for injection)
7,947,724 
7,947,725 
7,960,424 
8,598,219 
8,729,094
Helsinn Healthcare S.A. v. Fresenius Kabi USA, LLC, 15-0865 (D. Del.) Sept. 24, 2015 Hon. Gregory M. Sleet Aloxi® (palonosetron hydrochloride for injection)
7,947,724 
7,947,725 
7,960,424
8,598,219 
8,729,094
Amneal Pharms. LLC v. Yeda Research and Development Co., Ltd., IPR2015-01976 (PTAB) Sept. 25, 2015 N/A Copaxone® (glatiramer acetate for injection) 8,232,250
Amneal Pharms. LLC v. Yeda Research and Development Co., Ltd., IPR2015-01980 (PTAB) Sept. 25, 2015 N/A Copaxone® (glatiramer acetate for injection) 8,399,413
Amneal Pharms. LLC v. Yeda Research and Development Co., Ltd., IPR2015-01981 (PTAB) Sept. 25, 2015 N/A Copaxone® (glatiramer acetate for injection) 8,969,302
Coalition For Affordable Drugs V LLC v. Biogen MA, Inc., IPR2015-01993 (PTAB) Sept. 28, 2015 N/A Tecfidera® (dimethyl fumarate delayed-release capsule) 8,399,514
Mylan Pharms. Inc. v. 3M Co., IPR2015-02002 (PTAB) Sept. 29, 2015 N/A
Ventolin HFA® (albuterol sulfate inhalator) 
 
Flovent HFA® (fluticasone propionate inhalator) 
 
Advair HFA® (fluticasone propionate / salmeterol xinafoate inhalator)
6,743,413
Salix Pharms., Inc. v. Apotex, Inc., 15-0880 (D. Del.) Sept. 30, 2015 Hon. Gregory M. Sleet Giazo® (balsalazide disodium tablets)
6,197,341 
8,497,256
Back to Top